Lassen Therapeutics Funding: $85M Raised, Series B (2023)
Lassen Therapeutics is based in San Diego, California. It has raised $85M in total funding. Latest round: Series B.
Lassen Therapeutics funding overview
Lassen Therapeutics is based in San Diego, California. Lassen Therapeutics has raised $85M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in December 2023. The round record for Lassen Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Frazier Life Sciences, Longitude Capital, BVF Partners, Catalio Capital Management, Alta Partners, Longwood Capital. 6 distinct backers are named across the disclosed rounds.
Lassen Therapeutics at a glance
Total raised
$85M
Latest round
Series B
Latest round date
December 2023
Headquarters
San Diego, California
Notable investors
Frazier Life Sciences, Longitude Capital, BVF Partners, Catalio Capital Management, Alta Partners, Longwood Capital
Frequently asked about Lassen Therapeutics funding
How much has Lassen Therapeutics raised?
Lassen Therapeutics has raised $85M in total disclosed funding across the rounds on record.
Who has invested in Lassen Therapeutics?
Frazier Life Sciences, Longitude Capital, BVF Partners, Catalio Capital Management, Alta Partners, Longwood Capital are named among the investors backing Lassen Therapeutics.
What was the latest Lassen Therapeutics funding round?
The most recent disclosed round is a Series B, announced in December 2023.
Where is Lassen Therapeutics based?
Lassen Therapeutics is based in San Diego, California.
When did Lassen Therapeutics last raise?
The last disclosed Lassen Therapeutics round closed in December 2023 at Series B.
Every Lassen Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Diego at a similar stage.
